TNF and rheumatic disorder: TNF-α-blocking therapy has had a remarkable effect on disease activity in an increasing number of rheumatic diseases, including rheumatoid arthritis (RA) [1-3], juvenile idiopathic arthritis [4], ankylosing spondylitis [5,6], and psoriatic arthritis [7].